{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T18:41:44Z","timestamp":1775500904664,"version":"3.50.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"UK National Institute of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome Trust"},{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"crossref","award":["WT 088908\/Z\/09\/Z"],"award-info":[{"award-number":["WT 088908\/Z\/09\/Z"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"UK National Institute of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.vaccine.2010.10.044","type":"journal-article","created":{"date-parts":[[2010,10,30]],"date-time":"2010-10-30T08:21:12Z","timestamp":1288426872000},"page":"913-919","source":"Crossref","is-referenced-by-count":20,"title":["Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination"],"prefix":"10.1016","volume":"29","author":[{"given":"Helen C.","family":"Koenig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector S.","family":"Izurieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.10.044_bib0005","first-page":"738","article-title":"Wakefield tells GMC he was motivated by concern for autistic children","volume":"336","author":"Dyer","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0010","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0015","first-page":"49583","article-title":"International conference on harmonisation; guidance on statistical principles for clinical trials; availability \u2013 FDA. Notice","volume":"63","year":"1998","journal-title":"Fed Regist"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0020","unstructured":"MedDRA (Medical Dictionary for Regulatory Activities), Regulatory Mandate Status Update, 2010; 2009."},{"key":"10.1016\/j.vaccine.2010.10.044_bib0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0030","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0035","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) \u2013 United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0040","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0045","series-title":"Adverse events associated with childhood vaccines: evidence bearing on causality","first-page":"118","author":"Institute of Medicine, Measles and Mumps Vaccines","year":"1994"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0050","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1542\/peds.2007-1578","article-title":"Risk of immune thrombocytopenic purpura after measles\u2013mumps\u2013rubella immunization in children","volume":"121","author":"France","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0060","series-title":"Immunization safety review. Influenza vaccines and neurological complications","author":"Institute of Medicine (IOM)","year":"2003"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0301-0546(03)79278-7","article-title":"Adverse reactions to vaccines","volume":"31","author":"Eseverri","year":"2003","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0070","first-page":"10","article-title":"Vaccine allergy and pseudo-allergy","volume":"13","author":"Ponvert","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0075","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2009.196","article-title":"Vaccines and autoimmunity","volume":"5","author":"Agmon-Levin","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbspin.2004.12.003","article-title":"Osteoarticular side effects of BCG therapy","volume":"73","author":"Clavel","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0085","doi-asserted-by":"crossref","DOI":"10.1097\/PEC.0b013e31802d4b87","article-title":"Pediatric anaphylaxis","volume":"23","author":"Lane","year":"2007","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0090","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0095","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2249.1990.tb05458.x","article-title":"Intra-articular immunization induces strong systemic immune response in humans","volume":"82","author":"Trollmo","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0100","series-title":"Vaccines and Related Biological Products Advisory Committee Meeting Presentations","author":"U.S. Food and Drug Administration","year":"2009"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0105","doi-asserted-by":"crossref","DOI":"10.1203\/PDR.0b013e31819dbd0a","article-title":"An integrated classification of pediatric inflammatory diseases, based on the concepts of autoinflammation and the immunological disease continuum","author":"McGonagle","year":"2009","journal-title":"Pediatr Res"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2010.10.044_bib0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1556\/OH.2007.28030","article-title":"Types of autoimmune disorders. Classification","volume":"148","author":"Zeher","year":"2007","journal-title":"Orv Hetil"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2009.09.015","article-title":"Innate and adaptive autoimmunity directed to the central nervous system","volume":"64","author":"Bhat","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930701619490","article-title":"Autoantibody-mediated disorders of the central nervous system","volume":"41","author":"Irani","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0125","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archneur.62.11.1673","article-title":"Acute disseminated encephalomyelitis: an update","volume":"62","author":"Menge","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0130","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0135","article-title":"Has the time come to rethink the pathogenesis of asthma?","author":"Holgate","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0140","first-page":"S58","article-title":"Toll-like-receptor gene polymorphisms in a Tunisian population with Behcet's disease","volume":"27","author":"Ben Dhifallah","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0145","article-title":"The \u201cother\u201d vasculitis syndromes and kidney involvement","author":"Ozen","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0150","article-title":"Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states","author":"Macaubas","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0155","first-page":"527","article-title":"New insights into the pathogenesis of Crohn's disease: are they relevant for therapeutic options?","volume":"139","author":"Vavricka","year":"2009","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)","volume":"27","author":"Masters","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-3083.2008.02114.x","article-title":"The importance of \u2018Mechnikov's thorn\u2019 for an improved understanding of 21st century medicine and immunology: a view from the eye","volume":"68","author":"McGonagle","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0175","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0180","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3899\/jrheum.090682","article-title":"Unraveling the etiology of systemic autoimmune diseases: peering into the preclinical phase of disease","volume":"36","author":"Cooper","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3181\/00379727-91-22179","article-title":"Development of arthritis, periarthritis and periostitis in rats given adjuvants","volume":"91","author":"Pearson","year":"1956","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0190","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1177\/0961203309346975","article-title":"Vaccination of healthy subjects and autoantibodies: from mice through dogs to humans","volume":"18","author":"Toplak","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0195","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1442-200X.2007.02458.x","article-title":"Idiopathic thrombocytopenic purpura following measles\u2013rubella-conjugated vaccine","volume":"49","author":"Kitazawa","year":"2007","journal-title":"Pediatr Int"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0200","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2249.2005.02923.x","article-title":"Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine","volume":"142","author":"Martinuc Porobic","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0205","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.autrev.2008.07.008","article-title":"Autoimmune response following annual influenza vaccination in 92 apparently healthy adults","volume":"8","author":"Toplak","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0210","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1172\/JCI29943","article-title":"Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics","volume":"117","author":"Merbl","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0215","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.vaccine.2008.10.044","article-title":"Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990\u20132007","volume":"27","author":"Niu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1586\/14760584.2.2.167","article-title":"Survey of human-use adjuvants","volume":"2","author":"Kenney","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0225","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1084\/jem.96.6.605","article-title":"Studies on the generalized Shwartzman reaction: I. General observations concerning the phenomenon","volume":"96","author":"Thomas","year":"1952","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0235","article-title":"\u2018ASIA\u2019 \u2013 autoimmune\/inflammatory syndrome induced by adjuvants","author":"Shoenfeld","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0240","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/CMR.16.4.637-646.2003","article-title":"Role of toll-like receptors in pathogen recognition","volume":"16","author":"Janssens","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4889(01)00182-3","article-title":"Toll-like receptors as adjuvant receptors","volume":"1589","author":"Kaisho","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0250","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1203\/00006450-200109000-00004","article-title":"Toll-like receptors as sensors of pathogens","volume":"50","author":"Hallman","year":"2001","journal-title":"Pediatr Res"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0255","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20082316","article-title":"Unc93B1 biases toll-like receptor responses to nucleic acid in dendritic cells toward DNA \u2013 but against RNA-sensing","volume":"206","author":"Fukui","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0260","article-title":"Emerging treatment strategies and potential therapeutic targets in primary Sjogren's syndrome","author":"Becker","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0265","doi-asserted-by":"crossref","first-page":"12061","DOI":"10.1073\/pnas.0905441106","article-title":"Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus","volume":"106","author":"Kono","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0270","unstructured":"Baylor NW. Public workshop: adjuvants and adjuvanted preventive and therapeutic vaccines for infectious disease indications. Presented in Bethesda, MD, December 2\u20133, 2008; 2008\/2010."},{"key":"10.1016\/j.vaccine.2010.10.044_bib0275","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1345\/aph.1L495","article-title":"Serum sickness-like reaction associated with efalizumab","volume":"43","author":"Ashraf-Benson","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0280","article-title":"Serum sickness like reaction in an 11-year-old boy","author":"OKeeffe","year":"2009","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0285","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0290","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1086\/599615","article-title":"Serum sickness-like reaction associated with inactivated influenza vaccination among Thai health care personnel: risk factors and outcomes","volume":"49","author":"Apisarnthanarak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0264-410X(86)90096-4","article-title":"Immune complex-like disease in 23 persons following a booster dose of rabies human diploid cell vaccine","volume":"4","author":"Dreesen","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0300","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0305","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10408368009108728","article-title":"Soluble immune complexes in human disease","volume":"12","author":"Nydegger","year":"1980","journal-title":"CRC Crit Rev Clin Lab Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2010.10.044_bib0310","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.jcpa.2007.04.012","article-title":"Mechanisms underlying adverse reactions to vaccines","volume":"137","author":"Siegrist","year":"2007","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0315","first-page":"2181","article-title":"Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis","volume":"31","author":"Begier","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0320","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.284.10.1271","article-title":"Postlicensure safety surveillance for varicella vaccine","volume":"284","author":"Wise","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0325","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1172\/JCI17349","article-title":"A full complement of receptors in immune complex diseases","volume":"110","author":"Ravetch","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0330","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1189\/jlb.0108009","article-title":"Migration inhibitory factor (MIF) released by macrophages upon recognition of immune complexes is critical to inflammation in Arthus reaction","volume":"85","author":"Paiva","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0335","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.it.2008.12.004","article-title":"Linking allergy to autoimmune disease","volume":"30","author":"Valenta","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0340","first-page":"54","article-title":"Nonallergic hypersensitivity to nonsteroidal antiinflammatory drugs, angiotensin-converting enzyme inhibitors, radiocontrast media, local anesthetics, volume substitutes and medications used in general anesthesia","volume":"17","author":"Jurakic Toncic","year":"2009","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0345","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0350","first-page":"211","article-title":"Molecular mimicry of bacterial polysaccharides and their role in etiology of infectious and autoimmune diseases","volume":"55","author":"Korzeniowska-Kowal","year":"2001","journal-title":"Postepy Hig Med Dosw"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jaut.1999.0346","article-title":"Vaccination and autoimmunity-\u2019vaccinosis\u2019: a dangerous liaison?","volume":"14","author":"Shoenfeld","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0360","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.mehy.2007.04.043","article-title":"Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antigen complimentarity in the presence of an immunologic adjuvant and specific HLA patterns","volume":"70","author":"Waisbren","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0365","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/CMR.11.3.555","article-title":"Campylobacter species and Guillain-Barre syndrome","volume":"11","author":"Nachamkin","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0370","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","article-title":"Vaccines and Guillain-Barre syndrome","volume":"32","author":"Haber","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0375","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","article-title":"Guillain-Barre syndrome: an update","volume":"16","author":"Vucic","year":"2009","journal-title":"J. Clin Neurosci"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0380","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJM199912303412707","article-title":"Molecular mimicry and autoimmunity","volume":"341","author":"Albert","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0385","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/art.24418","article-title":"HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination","volume":"60","author":"Ball","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0390","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0395","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00271881","article-title":"Immunological and bacteriological aspects of reactive arthritis","volume":"9","author":"Toivanen","year":"1989","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0400","first-page":"S71","article-title":"An unusual case of Behcet's syndrome: triggered by typhoid vaccination?","volume":"22","author":"Molloy","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0405","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/s10165-008-0140-2","article-title":"Reactive arthritis following tetanus vaccination: a case report","volume":"19","author":"Sahin","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0410","first-page":"345","article-title":"A seventy-four-year-old man with bilateral conjunctival hyperemia, urinary symptoms, and secondary reactive arthritis following the administration of the BCG vaccine","volume":"144","author":"Valenzuela-Suarez","year":"2008","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0415","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/s10165-005-0399-5","article-title":"Reactive arthritis after influenza vaccination: report of a case","volume":"15","author":"Asakawa","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0420","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00296-006-0185-5","article-title":"Reactive arthritis following tetanus and rabies vaccinations","volume":"27","author":"Aksu","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0425","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/518800","article-title":"Genetic predisposition for adverse events after vaccination","volume":"196","author":"Crowe","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0430","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/588670","article-title":"Genetic basis for adverse events after smallpox vaccination","volume":"198","author":"Reif","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0435","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1651-2227.1997.tb08620.x","article-title":"Familial liability to complications after BCG vaccination","volume":"86","author":"Banac","year":"1997","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0440","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ejim.2007.06.035","article-title":"Systemic polyarteritis nodosa following hepatitis B vaccination","volume":"19","author":"de Carvalho","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0445","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0029-1233537","article-title":"Vaccination as a triggering event for autoimmune hepatitis","volume":"29","author":"Perumalswami","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0450","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tox.2003.10.005","article-title":"Autoimmunity, environmental exposure and vaccination: is there a link?","volume":"196","author":"Ravel","year":"2004","journal-title":"Toxicology"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0455","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1933","article-title":"Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders","volume":"39","author":"Durand","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0460","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng1136","article-title":"Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism","volume":"34","author":"Jamain","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0465","unstructured":"Centers for Disease Control and Prevention (CDC), Vaccine Safety Datalink (VSD) Project; 2009."},{"key":"10.1016\/j.vaccine.2010.10.044_bib0470","unstructured":"National Vaccine Program Office, Department of Health and Human Services, A Comprehensive Review of Federal Vaccine Safety Programs and Public Health Activities; 2008\/2010."},{"key":"10.1016\/j.vaccine.2010.10.044_bib0475","series-title":"Modern epidemiology","author":"Rothman","year":"2008"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0480","article-title":"The role of toll-like receptors in chronic inflammation","author":"Drexler","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0485","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00019052-200206000-00018","article-title":"Neurological adverse events associated with vaccination","volume":"15","author":"Piyasirisilp","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0490","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.2174\/092986708786848712","article-title":"Kawasaki's disease, acrodynia, and mercury","volume":"15","author":"Mutter","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.vaccine.2010.10.044_bib0495","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.mehy.2005.02.044","article-title":"Multiple sclerosis and hepatitis B vaccination: could minute contamination of the vaccine by partial hepatitis B virus polymerase play a role through molecular mimicry?","volume":"65","author":"Faure","year":"2005","journal-title":"Med Hypotheses"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10015288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10015288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T20:49:06Z","timestamp":1588798146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10015288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0264410X10015288"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.10.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}